The deal priced below last closing price of $22.54. Jefferies, Leerink, Evercore ISI and Guggenheim are acting as joint book running managers for the offering.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTA:
- Centessa announces American Depositary Shares offering, no amount given
- Centessa Pharmaceuticals: Promising Developments in Sleep Disorder Treatments Drive Buy Rating
- Centessa Pharmaceuticals Advances OX2R Agonist Program
- RBC says Centessa data highlights ‘impressive profile’ of Alkermes’ alixorexton
- Centessa narcolepsy data not superior to Alkermes, says Stifel